Skip to content
JCP
PCC
News
CME
About
Authors & Reviewers
Sign In
Subscribe
Search
Advanced Search
Sign in
Menu
JCP
PCC
News
CME
About
Authors & Reviewers
Sign In
Subscribe
Clinical Topics
View All
Addiction
Anxiety
Bipolar Disorder
Depression
Emerging Approaches in Schizophrenia
Movement Disorders
Neurology
OCD
Psychopharmacology
PTSD and Trauma
Schizophrenia/Schizoaffective Disorders
Tardive Dyskinesia
View All
Collections
View All
Academic Highlights
Auvelity: Information from Industry
Banner Alzheimer’s Institute
Clinical & Practical Psychopharmacology
Early Career Psychiatrists
Focus on Childhood and Adolescent Mental Health
Focus on Geriatric Psychiatry
Focus on Psychotherapy
Focus on Suicide
Focus on Psychosis
Focus on Women’s Mental Health
Rounds in the General Hospital
View All
InfoPack
JCP
InfoPack
Emerging Treatments in Schizophrenia
February 15, 2022
Experts discuss the brain circuits involved in schizophrenia, the current medications, and new agents in phase 3 trials that do not directly block postsynaptic D2 receptors. Phase 2 data...
Christoph U. Correll
,
Anissa Abi-Dargham
,
Oliver Howes
JCP
InfoPack
Improving Outcomes in Patients With Bipolar Depression: A Comprehensive Review
March 25, 2015
Andrew A. Nierenberg
,
Roger S. McIntyre
,
Gary S. Sachs
JCP
InfoPack
Clinical and Cost Implications of Treating Schizophrenia: Safety, Efficacy, Relapse Prevention, and Patient Outcomes
August 26, 2014
John M. Kane
,
Christoph U. Correll
,
Philip D. Harvey
, et al
JCP
InfoPack
How to Interpret Findings Concerning Newly Approved Antipsychotic Agents: Clinical Implications of the Lurasidone PEARL 2 Study
August 15, 2012
Christoph U. Correll
,
John Lauriello
,
Ashok Malla
, et al
